Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
US8557245B2 · kind B2 · utility
15Cited by
0References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 13, 2012 |
| Grant date | Oct 15, 2013 |
| Priority date | — |
| Expiry date | Jun 13, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.